Table 1. Relationship between HSPC111 and nuclear YAP1 expression and clinicopathological variables (n – 120).
| Variables | Number | YAP1 expression | P value | HSPC111 expression | P value | ||
|---|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | ||||
| Gender | 0.698 | 0.617 | |||||
| Male | 87 | 43 (49.4) | 44 (50.6) | 36 (41.4) | 51 (58.6) | ||
| Female | 33 | 15 (45.45) | 18 (54.5) | 12 (36.4) | 21 (63.6) | ||
| Age* | 0.273 | 0.456 | |||||
| > 57.5 | 60 | 32 (53.3) | 28 (46.7) | 22 (36.7) | 38 (63.3) | ||
| < 57.5 | 60 | 26 (43.3) | 34 (56.7) | 26 (43.3) | 34 (56.7) | ||
| Depth of invasion | 0.353 | 0.437 | |||||
| T1/2 | 38 | 16 (42.1) | 22 (57.9) | 13 (34.2) | 25 (65.7) | ||
| T3/4 | 82 | 42 (51.2) | 40 (48.8) | 35 (42.7) | 47 (57.3) | ||
| LNM | 0.007 | 0.014 | |||||
| Yes | 46 | 15 (32.6) | 31 (67.4) | 12 (26.1) | 34 (73.9) | ||
| No | 74 | 43 (58.1) | 31 (41.9) | 36 (48.6) | 38 (51.4) | ||
| Tumor size | 0.023 | 0.184 | |||||
| < 6 cm | 101 | 48 (47.5) | 53 (52.5) | 43 (42.6) | 58 (57.4) | ||
| > = 6 cm | 19 | 10 (52.6) | 9 (47.4) | 5 (26.3) | 14 (73.7) | ||
| Differentiation | 0.298 | 0.057 | |||||
| Low/undifferentiated | 86 | 39 (45.3) | 47 (54.7) | 39 (45.3) | 47 (54.7) | ||
| High/moderate | 34 | 19 (55.9) | 15 (44.1) | 9 (26.5) | 25 (73.5) | ||
| TNM stage | 0.041 | 0.454 | |||||
| I/II | 55 | 21 (38.2) | 34 (61.8) | 20 (36.4) | 35 (63.6) | ||
| III | 65 | 37 (56.9) | 28 (43.1) | 28 (43.1) | 37 (56.9) | ||
Age* = mean age; LNM = lymph node metastasis.